A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above
PHASE3
The aim of this study is to assess the immunogenicity, safety and reactogen...
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers
PHASE2
The purpose of this study is to assess the safety, reactogenicity and immun...
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age
PHASE1
The purpose of this study was to evaluate the safety, infectivity, and immu...
Status
Completed
Location
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program